Liminatus Pharma, Inc. (LIMN)

0.2476 +0.02 (+8.12%) USD  |  NASDAQ  |  Feb 23, 13:00
More

Liminatus Pharma Non-Operating Interest Expense (Quarterly)

Non-Operating Interest Expense (Quarterly) Chart

View Non-Operating Interest Expense (Quarterly) for LIMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Operating Interest Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Operating Interest Expense (Quarterly) Range, Past 5 Years

View Non-Operating Interest Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Operating Interest Expense (Quarterly) Benchmarks

View Non-Operating Interest Expense (Quarterly) Benchmarks
Start Trial
CDT Equity, Inc. Upgrade
LENZ Therapeutics, Inc. Upgrade
Oruka Therapeutics, Inc. Upgrade
Maze Therapeutics, Inc. Upgrade
MapLight Therapeutics, Inc. Upgrade